Investor Presentation • Sep 18, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
INVESTOR PRESENTATION



JAN DRAHOTA Chairman of the Board of Directors Colt CZ Group SE

RADEK MUSIL Vice-chairman of the Board of Directors CEO of Colt CZ Group SE

JAN ZAJÍC Member of the Board of Directors CEO of Česká zbrojovka a.s.

JANA MATOUŠKOVÁ Head of Group Finance Colt CZ Group SE
REVENUES CZK 11,015 m ↑ 13.7% vs 6M 2024 LTM: CZK 24,579 m ADJUSTED EBITDA CZK 2,361 m ↑ 19.2% vs 6M 2024 LTM: CZK 5,210 m
PPA IMPACT CZK 303 m or CZK 5.3 per share

ADJUSTED EPS ↓ 28.4% vs 6M 2024 CZK 17.8 LTM: CZK 37.4

Ammunition segment retains excellent profitability, growing on the European market, able to offset US commercial market softness.
Firearms - H1 2025 performance slower than expected for CZ and Colt WH, only Colt Canada performed above 2024 YTD.
CZ is doing well on the slower US commercial market (flat y/y even with price increase), but some key MLE project delayed to Q3 and Q4, expected to catch up in Q3 and Q4.
Colt WH - weakest performer of the Group in 2025 - both on the US commercial market (slower introduction of new models), delay in key large MLE contracts (some of them record high, but regulatory process taking longer than expected).
US tariffs in majority passed on the consumer (firearms), to the sales price, FX rates influencing the Revenues/EBITDA (apart of the translation risk offset in the financial income of the Group).
Sellier & Bellot, has signed a five-year strategic partnership agreement for the supply of high-performance propellants with EURENCO. Česká zbrojovka signed Framework Agreement with Ministry of Defence for the years 2025 to 2031. Colt Canada signed a significant contract with the Danish Ministry of Defence Acquisition and Logistics (DALO), for the supply of 26,000 C8 MRR carabines.








BREAKDOWN BY FIREARMS UNITS SOLD


In '000 units

Short guns Long guns





COMMENTS
FY 2025 CAPEX guidance in line with medium-term strategy
Main part of CAPEX 2025 was realized in the Czech Republic in both – R&D and machinery



Notes: 1 – Net financial debt is defined as long-term and short-term bonds, bank loans and borrowings and finance lease liabilities (non-current and current), less cash and cash equivalents, less other current financial assets (marketable securities) 2 – Net leverage ratio is defined as the ratio of net financial debt at the end of the period to LTM adjusted EBITDA, formula based on the loan legal documentation
The transaction values 100% of SNC at CZK 20.6bn and 100% of energy business, at CZK 1.4bn at Enterprise Value
Transaction multiple at 8.2x EV/EBITDA
Current Colt CZ trading multiple 9-10x
Producers of military propellants and explosives (Chemring, Rheinmetall, BAE) trade at ~ 15x-35x EV/EBITDA
The extension of our core business into a new segment should allow for multiple expansion

Cash consideration of CZK 5.5bn
Expected stock consideration of around CZK 3.7bn based on the following assumptions at closing:
Expected stock consideration CZK 714m based on the following assumptions at closing:

Exercise period during 2 years starting 24 months after closing Cash consideration CZK 3.5bn Expected stock consideration CZK 5.3bn based on the following assumptions at the second closing:
Exercise period during 2 years starting 48 months after closing All cash consideration CZK 8.8bn based on the following assumptions at the second closing:
Net Debt EUR 107m
Exercise period same as SNC Expected stock consideration at CZK 686m adjusted for actual net debt


16
REVENUES
CZK 25 bn plus/minus 10% EBITDA CZK 5.5 bn plus/minus 10%
| CZK bn | Q 1 |
Q 2 |
Q 3 |
Q 4 |
FY 2025 |
|---|---|---|---|---|---|
| Revenues | 5.5 | 5.5 | 5.0 | 9.0 | 25 |
| Adj. EBITDA | 1.2 | 1.1 | 1.2 | 2.0 | 5.5 |

Notes: Guidance is based on the management expectations as of the date of presentation SNC acquisition not included




| In CZK '000 | 6M 2025 | 6M 2024 |
|---|---|---|
| Operating profit | 1 587 284 | 898 774 |
| Depreciation and amortization | 770 968 | 560 821 |
| EBITDA | 2 358 252 | 1 459 595 |
| ESOP related costs | 30 945 | 382 185 |
| M&A costs | 15 218 | 962 |
| Legacy costs | 5 389 | - |
| S&B inventory step up | - | 110 000 |
| S&B commodity hedging | (48 734) | 28 016 |
| Adjusted EBITDA | 2 361 069 | 1 980 758 |

| In CZK '000 | 6M 2025 | 6M 2024 |
|---|---|---|
| Earnings before tax | 1 195 680 | 794 788 |
| Tax expenses | (276 414) | (185 170) |
| Net income | 919 266 | 609 618 |
| ESOP related costs | 30 945 | 382 185 |
| M&A costs | 15 218 | 962 |
| Legacy cost | 5 389 | - |
| S&B inventory step up | - | 110 000 |
| Bank fee – acquisition loan S&B | 41 761 | 30 634 |
| Expenses of IRS cancellation related to early repayment of loan | 7 955 | - |
| One-off expenses related to the bond issue | 6 402 | 4 838 |
| Adjusted earnings before tax (Adj. EBT) | 1 303 350 | 1 323 407 |
| Effective tax rate on Adj. EBT (2025 ~23.1%; 2024 ~23.3%) | (301 305) | (308 328) |
| Adjusted Net Income | 1 002 045 | 1 015 079 |
| In CZK '000 000; | G 2025 |
|---|---|
| Interest expenses | 852 |
| Hedging impact | (112) |
| Deposit revenues | (141) |
| Net interest costs | 599 |
| Effective interest rate | 3,64% |

| In '000 CZK | 30 Jun 2025 | 30 Jun 2024 |
|---|---|---|
| Revenues from the sale of own products, goods and services | 11 014 802 | 9 690 015 |
| Other operating income | 850 778 | 217 161 |
| Change in inventories developed internally | (5 570 674) | (5 453 456) |
| Own work capitalized | (2 502 828) | (2 226 294) |
| Raw materials and consumables used | (770 968) | (560 821) |
| Services | (1 331 255) | (1 098 262) |
| Personnel costs | 55 243 | 67 122 |
| Depreciation and amortization | 143 985 | 406 861 |
| Other operating expenses | (259 231) | (164 827) |
| Allowances | (42 568) | 21 275 |
| Operating profit | 1 587 284 | 898 774 |
| Interest income | 281 015 | 418 014 |
| Interest expense | (556 672) | (558 422) |
| Other financial income | 3 233 | 85 496 |
| Other financial expenses | (373 343) | (63 837) |
| Gains or losses from derivative transactions | 250 323 | 13 854 |
| Share in the profit of associates after tax | 3 840 | 909 |
| Profit before tax | 1 195 680 | 794 788 |
| Income tax | (276 414) | (185 170) |
| Profit for the period | 919 266 | 609 618 |
| Items that may be subsequently reclassified to the statement of profit or loss | ||
| Cash flow hedges – remeasurement of effective portion of hedging instruments | 382 339 | (179 440) |
| Foreign currency translation of foreign operations | (306 975) | 25 528 |
| Other comprehensive income | 75 364 | (153 912) |
| Comprehensive income for the period | 994 630 | 455 706 |
| Profit for the period attributable to: | ||
| Owner of the parent company | 919 266 | 609 618 |
| Comprehensive income for the period attributable to: | ||
| Owner of the parent company | 994 630 | 455 706 |
| Net earnings per share attributable to the owner of the parent company (CZK per share) | ||
| Basic | 16 | 15 |
| Diluted | 16 | 15 |

| In CZK '000 | 30 Jun 2025 | 31 Dec 2024 |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Intangible assets | 9 797 868 | 10 403 416 |
| Goodwill | 9 025 018 | 8 489 707 |
| Property, plant and equipment | 9 779 922 | 9 582 545 |
| Equity-accounted securities and investments | 47 943 | 44 102 |
| Financial derivatives | 844 755 | 413 372 |
| Trade and other receivables | 11 766 | 20 021 |
| Other receivables | 2 132 | 2 593 |
| Deferred tax assets | 72 269 | 75 589 |
| Total non-current assets | 29 581 673 | 29 031 345 |
| Current assets | ||
| Inventories | 8 809 146 | 7 456 512 |
| Trade and other receivables | 2 066 369 | 2 829 759 |
| Provided loans | 19 180 | 20 017 |
| Other financial assets | 11 134 | 12 531 |
| Financial derivatives | 465 245 | 127 174 |
| Other receivables | 440 095 | 555 882 |
| Tax receivables | 154 385 | 81 210 |
| Cash and cash equivalents | 3 452 305 | 5 917 768 |
| Total current assets | 15 417 859 | 17 000 853 |
| Total assets | 44 999 532 | 46 032 198 |
| In CZK '000 | 30 Jun 2025 | 31 Dec 2024 |
|---|---|---|
| EQUITY AND LIABILITIES | ||
| Capital and reserves | ||
| Share capital | 5 646 | 5 646 |
| Share premium | 13 477 795 | 13 477 795 |
| Capital funds | 1 641 512 | 1 641 512 |
| Cash flow hedge reserve | 178 845 | (203 494) |
| Foreign exchange translation reserve | (375 112) | (68 137) |
| Accumulated profits | 5 276 568 | 5 175 107 |
| Equity attributable to the owner of the Company | 20 205 254 | 20 028 429 |
| Non-controlling interest | - | - |
| Total equity | 20 205 254 | 20 028 429 |
| Non-current liabilities | ||
| Bonds, bank loans and borrowings | 14 494 844 | 16 336 227 |
| Financial derivatives | 217 510 | 532 473 |
| Lease liabilities | 53 390 | 58 922 |
| Trade and other payables | 68 726 | 46 802 |
| Other payables | 7 289 | 10 387 |
| Provisions | 101 732 | 101 095 |
| Deferred tax liability | 2 602 536 | 2 561 948 |
| Employee benefit liabilities | 204 085 | 234 725 |
| Total non-current liabilities | 17 750 112 | 19 882 579 |
| Current liabilities | ||
| Bonds, bank loans and borrowings | 1 499 060 | 1 474 910 |
| Financial derivatives | 259 778 | 394 262 |
| Lease liabilities | 21 457 | 22 267 |
| Trade and other payables | 2 394 545 | 1 573 335 |
| Other payables | 2 654 952 | 2 333 203 |
| Provisions | 79 191 | 57 870 |
| Tax liabilities | 117 329 | 248 236 |
| Employee benefit liabilities | 17 854 | 17 107 |
| Total current liabilities | 7 044 166 | 6 121 190 |
| Total liabilities | 24 794 278 | 26 003 769 |
| Total equity and liabilities | 44 999 532 | 46 032 198 |
| In '000 CZK | 30 Jun 2025 | 30 Jun 2024 |
|---|---|---|
| Cash flows from principal economic activity (operating activity) | ||
| Profit from ordinary activity before tax | 1 195 680 | 794 788 |
| Depreciation/amortization of non-current assets | 770 968 | 560 821 |
| Change in allowances and provisions | 69 504 | 24 940 |
| Gain/Loss on sale of fixed assets | (1 159) | (1 392) |
| Interest expense and interest income | 275 657 | 140 408 |
| Share in the profit of associates | (3 841) | (909) |
| Unrealized foreign exchange gain and losses | 830 216 | (133 551) |
| Other financial assets – remeasurement | - | (113 402) |
| Cash flow hedging – remeasurement of the effective portion of hedging instruments | 382 339 | (179 440) |
| Share-based payments | 29 140 | 355 013 |
| Adjustments for other non-cash transactions | 57 277 | 31 380 |
| Net operation cash flows before changes in working capital | 3 605 781 | 1 478 656 |
| Change in working capital | (1 609 371) | (430 769) |
| Change in receivables and deferrals | (44 842) | (189 676) |
| Change in liabilities and accruals | 149 946 | (161 031) |
| Change in inventories | (1 714 475) | (80 062) |
| Cash flow from operating activities | 1 996 410 | 1 047 887 |
| Paid interest | (704 810) | (525 585) |
| Interest received | 429 443 | 429 610 |
| Income tax paid for ordinary activity | (587 099) | (521 795) |
| Net cash flow from operating activities | 1 133 944 | 430 117 |
| Cash flows from investing activities | ||
| Acquisition of non-current assets | (361 963) | (382 502) |
| Proceeds from the sale of non-current assets | 1 159 | 1 392 |
| Acquisition of equity-accounted securities and investments | - | (3 777) |
| Acquisition of subsidiaries - opening balance | (1 341 795) | (5 231 350) |
| Acwuidizion of subsidiaries - cash and cash equivalents | 8 460 | 443 521 |
| Employee benefit liabilities | - | - |
| Acquisition of other financial assets | - | - |
| Proceeds from sale of other financial assets | - | 1 021 982 |
| Provided loans | - | (18 979) |
| Net cash flow from investing activities | (1 694 139) | (4 169 713) |
| Cash flows from financing activities | ||
| Proceeds from issue of bonds | - | 276 000 |
| Proceeds from loans | 2 378 | 10 794 456 |
| Loan repayment | (1 726 254) | (5 701 743) |
| Leases repayment | (13 840) | (12 966) |
| Net cash flow from financing activities | (1 737 716) | 5 355 747 |
| Net change in cash and cash equivalents | (2 297 911) | 1 616 151 |
| Opening balance of cash and cash equivalents | 5 917 768 | 3 328 684 |
| Effect of exchange rate on cash and cash equivalents | (167 552) | 53 002 |
| Closing balance of cash and cash equivalents | 3 452 305 | 4 997 837 |




29
náměstí Republiky 2090/3a 110 00 Prague 1, Czech Republic www.coltczgroup.com [email protected]


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.